A. Herschtal

发表

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.

J. Lewin, G. McArthur, M. Shackleton, 2017 .

To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option.

J. Savulescu, J. Zalcberg, M. Jefford, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The enhanced recovery after surgery (ERAS) Greenie Board: a Navy‐inspired quality improvement tool

B. Riedel, A. Herschtal, A. Smirk, 2018, Anaesthesia.

A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies

J. Mariani, M. Dwyer, J. Seymour, 2019, Cancers.

18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma

B. Neyns, D. Milne, G. McArthur, 2020, Cancer Imaging.

Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases.

T. Eade, A. Kneebone, S. Siva, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Does inverse‐planned intensity‐modulated radiation therapy have a role in the treatment of patients with left‐sided breast cancer?

T. Kron, J. Cramb, A. Herschtal, 2011, Journal of medical imaging and radiation oncology.

Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.

A. Hogg, D. Ball, M. M. Mac Manus, 2011, International journal of radiation oncology, biology, physics.

Adverse respiratory outcomes following conventional long‐course radiotherapy for non‐small‐cell lung cancer in patients with pre‐existing pulmonary fibrosis: A comparative retrospective study

S. Siva, D. Ball, L. Irving, 2020, Journal of medical imaging and radiation oncology.

Prognostic significance of several histological features in intermediate and high‐risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy

M. Quinn, K. Narayan, A. Herschtal, 2009, Journal of medical imaging and radiation oncology.

Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer

T. Kron, D. Ball, R. Hicks, 2014 .

Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer

T. Kron, D. Ball, R. Hicks, 2014 .

Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer

T. Kron, D. Ball, R. Hicks, 2014, The Journal of Nuclear Medicine.

Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.

M. Lichtenstein, R. Hicks, D. Rischin, 2020, Gynecologic oncology.

Impact of 18F‐fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra‐pulmonary small‐cell cancer

D. Ball, R. Hicks, M. MacManus, 2010, Journal of medical imaging and radiation oncology.

Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.

B. Solomon, D. Rischin, S. Porceddu, 2020, Oral oncology.

Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.

A. Hogg, D. Ball, M. M. Mac Manus, 2009, International journal of radiation oncology, biology, physics.

Impact of post‐therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer

S. Siva, R. Hicks, K. Narayan, 2011, Cancer.

Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.

T. Kron, D. Ball, M. M. Mac Manus, 2017, International journal of radiation oncology, biology, physics.

Lung ASSOCIATION BETWEEN PULMONARY UPTAKE OF FLUORODEOXYGLUCOSE DETECTED BY POSITRON EMISSION TOMOGRAPHY SCANNING

Rodney, J., D. Binns, 2011 .

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

R. Hicks, M. Michael, M. Hofman, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma

S. Fox, N. Ferris, G. Powell, 2014, British Journal of Cancer.

Real-time Image-guided Adaptive-predictive Prostate Radiotherapy using Rectal Diameter as a Predictor of Motion.

T. Kron, F. Foroudi, R. Oates, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Should extrapulmonary small cell cancer be managed like small cell lung cancer?

D. Ball, M. M. Mac Manus, S. Brennan, 2010, Cancer.

Outcomes of Australian patients receiving non‐funded anti‐PD‐1 immune checkpoint inhibitors for non‐melanoma cancers

L. Mileshkin, A. Herschtal, A. Wong, 2018, Asia-Pacific journal of clinical oncology.

18 F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma

B. Neyns, D. Milne, G. McArthur, 2020 .

with for

Christopher, C. Tam, A. Schwarer, 2014 .

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma

J. Lewin, G. McArthur, M. Shackleton, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era.

C. Tam, J. Seymour, A. Herschtal, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre

J. Desai, S. Hendry, P. Choong, 2018, ANZ journal of surgery.

A phase I/II trial of combined BRAF and EGFR inhibition in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal (mCRC): The EViCT (Erlotinib and Vemurafenib in Combination Trial) study.

P. Gibbs, J. Desai, B. Solomon, 2017 .

Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.

B. Solomon, D. Rischin, S. Porceddu, 2017, International journal of radiation oncology, biology, physics.

64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

R. Hicks, M. Hofman, T. Akhurst, 2018, The Journal of Nuclear Medicine.

First-in-human trial of 64 Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy

R. Hicks, M. Hofman, T. Akhurst, 2018 .

Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy

T. Eade, A. Kneebone, L. Bell, 2015, Radiation oncology.

MA13.09 Serial FDG and FLT PET/CT during Curative-Intent Chemo-Radiotherapy for NSCLC Impacts Patient Management and May Predict Clinical Outcomes

T. Kron, D. Ball, R. Hicks, 2017 .

A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial

R. Fisher, H. Woo, M. Frydenberg, 2019, International Journal of Radiation Oncology*Biology*Physics.

Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy

T. Eade, A. Kneebone, L. Bell, 2015, Radiation oncology.

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2020, The Lancet.

Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers.

T. Kron, C. Fox, F. Foroudi, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Comparison of Bayesian Models of Heteroscedasticity in Nested Normal Data

Kerrie L. Mengersen, Farshad Foroudi, Alan Herschtal, 2016, Commun. Stat. Simul. Comput..

Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study.

Tomas Kron, Annette Haworth, Farshad Foroudi, 2011, International journal of radiation oncology, biology, physics.

Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study.

M. Krishnasamy, F. Foroudi, M. Bressel, 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network

T. Speed, Han Liang, T. Soussi, 2019, Nature Communications.

Going to extremes: determinants of extraordinary response and survival in patients with cancer

Dale W. Garsed, M. Pike, E. Goode, 2019, Nature Reviews Cancer.

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.

R. Fisher, H. Woo, M. Frydenberg, 2020, The Lancet Oncology.

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

D. Bailey, N. Lawrentschuk, D. Murphy, 2018, BJU international.

Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis

M. Henderson, D. Gyorki, A. Sanelli, 2016, Head & neck.

Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool

G. McArthur, S. Lazarakis, M. Henderson, 2016, Annals of Surgical Oncology.

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

David M. Thomas, M. Sydes, A. Bleyer, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subcutaneous Lidocaine Infusion for Pain in Patients with Cancer.

A. Herschtal, S. Fullerton, D. Seah, 2017, Journal of palliative medicine.

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.

C. Tam, A. Schwarer, D. White, 2015, Blood.

Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging.

Alan Herschtal, Sarah Everitt, J. Hayman, 2011, International journal of radiation oncology, biology, physics.

Randomised trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group study.

R. Fisher, D. Rischin, Lachlan McDowell, 2021, International journal of radiation oncology, biology, physics.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Tomas Kron, Andrew Wirth, Benjamin Solomon, 2019, The Lancet. Oncology.

SABR versus conventional fractionation regimens in NSCLC - Authors' reply.

D. Ball, A. Herschtal, 2019, The Lancet. Oncology.

Should Extrapulmonary Small Cell Cancer be Managed Like Small Cell Lung Cancer

D. Ball, M. MacManus, S. Brennan, 2009 .

Calculating geometrical margins for hypofractionated radiotherapy

T Kron, A Herschtal, F Foroudi, 2013, Physics in medicine and biology.

A Bayesian Approach for Prediction of Patient Radiosensitivity.

P. Lobachevsky, O. Martin, T. Leong, 2018, International journal of radiation oncology, biology, physics.

Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic

S. Kirsa, L. Mileshkin, D. Ball, 2016, Asia-Pacific journal of clinical oncology.

Optimising area under the ROC curve using gradient descent

Bhavani Raskutti, Alan Herschtal, Bhavani Raskutti, 2004, ICML.

MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL)

S. Vinod, T. Kron, J. Ruben, 2017 .

High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose‐positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer

M. Schneider-Kolsky, T. Kron, D. Ball, 2010, Cancer.

Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis

M. Sydes, C. Parker, S. Nénan, 2019, Annals of Oncology.

Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood

J. Desai, B. Seddon, M. Michael, 2018, Cancer Chemotherapy and Pharmacology.

The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data.

David Binns, Alan Herschtal, Rodney J Hicks, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Unilateral radiotherapy treatment for p16/human papillomavirus–positive squamous cell carcinoma of unknown primary in the head and neck

B. Solomon, D. Rischin, R. Young, 2018, The Laryngoscope.

Obtaining information on intra-fraction prostate displacement in radiotherapy determined from pre- and post-treatment kV imaging

T. Kron, F. Foroudi, A. Haworth, 2009 .

A pilot study on geometrical uncertainties for intra ocular cancers in radiotherapy

Stephen Todd, Annette Haworth, Alan Herschtal, 2017, Australasian Physical & Engineering Sciences in Medicine.

Sparing healthy tissue and increasing tumor dose using bayesian modeling of geometric uncertainties for planning target volume personalization.

K. Mengersen, T. Eade, T. Kron, 2015, International journal of radiation oncology, biology, physics.

Calculating radiotherapy margins based on Bayesian modelling of patient specific random errors

K. Mengersen, P. Greer, T. Eade, 2015, Physics in medicine and biology.

Finding the optimal statistical model to describe target motion during radiotherapy delivery—a Bayesian approach

T Kron, A Herschtal, F Foroudi, 2012, Physics in medicine and biology.

In pursuit of individualised margins for prostate cancer patients undergoing image-guided radiotherapy: the effect of body mass index on intrafraction prostate motion.

T. Kron, F. Foroudi, S. Gill, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy margin design with particular consideration of high curvature CTVs.

T. Kron, C. Fox, A. Herschtal, 2009, Medical physics.

Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma

A. R. Ravi Kumar, D. Gyorki, A. Herschtal, 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians

J. Lewin, K. Thompson, M. Sullivan, 2017, Sarcoma.

The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer.

M. Schneider-Kolsky, T. Kron, D. Ball, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate bed radiation therapy: the utility of ultrasound volumetric imaging of the bladder.

F. Foroudi, D. Pham, M. Bressel, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Rectal filling at planning does not predict stability of the prostate gland during a course of radical radiotherapy if patients with large rectal filling are re-imaged.

T. Kron, F. Foroudi, A. Haworth, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

The dosimetric impact of supraclavicular nodal irradiation on the thyroid gland in patients with breast cancer.

T. Kron, A. Herschtal, B. Chua, 2013, Practical radiation oncology.

Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: A planned interim analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502).

N. Lawrentschuk, I. Davis, P. Grimison, 2020 .